Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Jürgen Gallowitsch

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Wiener Medizinische Wochenschrift (1946)|January 21, 2006
[Thyroid and cardiovascular system]Hans-Jürgen Gallowitsch
Wiener Medizinische Wochenschrift (1946)|February 2, 2019
Hans-Jürgen Gallowitsch
Wiener Medizinische Wochenschrift (1946)|October 27, 2012
Nuclear medicine and oncologyPeter Lind, Hans-Jürgen Gallowitsch
Wiener Medizinische Wochenschrift (1946)|July 20, 2012
Nuclear medicine in NETManfred Sorschag, Phillip Malle, Hans-Jürgen Gallowitsch
Wiener Medizinische Wochenschrift (1946)|August 15, 2012
FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumoursPhilipp Malle, Manfred Sorschag, Hans-Jürgen Gallowitsch
Wiener Medizinische Wochenschrift (1946)|May 18, 2010
[Thyroid and pregnancy]Johanna Mayr, Susanne Kohlfürst, Hans-Jürgen Gallowitsch, et al.
Wiener Medizinische Wochenschrift (1946)|March 28, 2003
[Scintigraphic findings in a patient with sickle-cell thalassemia and recurrent pain attacks]Peter Mikosch, Barbara Jauk, Wilhelm Kaulfersch, et al.
Wiener Medizinische Wochenschrift (1946)|March 28, 2003
F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroidPeter Mikosch, Franz G Würtz, Hans-Jürgen Gallowitsch, et al.
Investigative Radiology|May 17, 2003
F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imagingHans-Jürgen Gallowitsch, Ewald Kresnik, Johann Gasser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2006
Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?Michael Zoller, Susanne Kohlfuerst, Isabel Igerc, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Wiener Medizinische Wochenschrift (1946)|January 21, 2006
[Thyroid and cardiovascular system]Hans-Jürgen Gallowitsch
Wiener Medizinische Wochenschrift (1946)|February 2, 2019
Hans-Jürgen Gallowitsch
Wiener Medizinische Wochenschrift (1946)|October 27, 2012
Nuclear medicine and oncologyPeter Lind, Hans-Jürgen Gallowitsch
Wiener Medizinische Wochenschrift (1946)|July 20, 2012
Nuclear medicine in NETManfred Sorschag, Phillip Malle, Hans-Jürgen Gallowitsch
Wiener Medizinische Wochenschrift (1946)|August 15, 2012
FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumoursPhilipp Malle, Manfred Sorschag, Hans-Jürgen Gallowitsch
Wiener Medizinische Wochenschrift (1946)|May 18, 2010
[Thyroid and pregnancy]Johanna Mayr, Susanne Kohlfürst, Hans-Jürgen Gallowitsch, et al.
Wiener Medizinische Wochenschrift (1946)|March 28, 2003
[Scintigraphic findings in a patient with sickle-cell thalassemia and recurrent pain attacks]Peter Mikosch, Barbara Jauk, Wilhelm Kaulfersch, et al.
Wiener Medizinische Wochenschrift (1946)|March 28, 2003
F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroidPeter Mikosch, Franz G Würtz, Hans-Jürgen Gallowitsch, et al.
Investigative Radiology|May 17, 2003
F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imagingHans-Jürgen Gallowitsch, Ewald Kresnik, Johann Gasser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2006
Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?Michael Zoller, Susanne Kohlfuerst, Isabel Igerc, et al.
Pageof 2